Bio Protocol vs HumidiFi — how do they compare? Bio Protocol trades at Rp516.9 (market cap Rp1,15T, Rp264,79M 24h volume), while HumidiFi trades at Rp1,224 (market cap Rp274,37M, Rp85,79M 24h volume). The key difference: Bio Protocol is far larger — about 4191.4× HumidiFi's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 230M / 1B WET (23%) for HumidiFi. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and HumidiFi for 6 Days on average.
| BIO | WET | |
|---|---|---|
Market Cap | Rp1,15T | Rp274,37M |
Volume (24h) | Rp264,79M | Rp85,79M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 230M / 1B WET (23%) |
Typical Hold Time | 16 Days | 6 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
HumidiFi (WET) trades at Rp1,225.56 with a market cap of Rp274.37 million, showing a bullish technical signal supported by moving averages. The token exhibits neutral oscillators but strong ADX readings indicating a solid trend. Key support lies at Rp1,174 and resistance at Rp1,243. No recent protocol updates or ecosystem news are available, limiting fundamental catalysts.
Overall outlook is cautiously optimistic based on technical strength, but low circulation rate (23%) and limited market cap pose liquidity risks. Opportunities include potential breakout above resistance, while major risks involve low adoption and high volatility typical of micro-cap cryptocurrencies. Investors should monitor volume increases for confirmation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →HumidiFi is Solana’s largest decentralized exchange by volume, processing over $1B daily and capturing ~35% of the network’s spot activity. As a “prop AMM”, it blends on-chain execution with institutional market-making logic to offer tighter spreads, deeper liquidity, and stronger execution than typical DEXs and CEXs.
Read more on WET →